HENDERSON MICHAEL THOMAS (Chief Executive Officer) sold 1.8% of their position (20K shares) of APOGEE THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.67M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 6 sales
Filed: 6/12/2026ACC: 0001104659-26-073567
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-20K
Net shares
Net seller
$1.67M
Total sold
6
Open market trades
0B · 6S
6
Total transactions
20K disposed
Non-Derivative Transactions6
Common Stock
Direct
Shares
−6.77K
Price / share
$82.21
Trade value
$556.56K
% of position
0.6%
6/10/2026
1.12M→1.11M
Common Stock
Direct
Shares
−7.65K
Price / share
$82.78
Trade value
$633.60K
% of position
0.7%
6/10/2026
1.11M→1.10M
Common Stock
Direct
Shares
−1.08K
Price / share
$84.18
Trade value
$90.91K
% of position
0.1%
6/10/2026
1.10M→1.10M
Common Stock
Direct
Shares
−1.58K
Price / share
$85.19
Trade value
$134.34K
% of position
0.1%
6/10/2026
1.10M→1.10M
Common Stock
Direct
Shares
−2.31K
Price / share
$86.27
Trade value
$198.85K
% of position
0.2%
6/10/2026
1.10M→1.10M
Common Stock
Direct
Shares
−614.00
Price / share
$86.89
Trade value
$53.35K
% of position
0.1%
6/10/2026
1.10M→1.10M
Total
Net shares
−20K
Net value
-$1.67M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/10/2026 | S · Sale | −6.77K | $82.21 | $556.56K | 0.6% | 1.12M | 1.11M |
| Common Stock Direct | 6/10/2026 | S · Sale | −7.65K | $82.78 | $633.60K | 0.7% | 1.11M | 1.10M |
| Common Stock Direct | 6/10/2026 | S · Sale | −1.08K | $84.18 | $90.91K | 0.1% | 1.10M | 1.10M |
| Common Stock Direct | 6/10/2026 | S · Sale | −1.58K | $85.19 | $134.34K | 0.1% | 1.10M | 1.10M |
| Common Stock Direct | 6/10/2026 | S · Sale | −2.31K | $86.27 | $198.85K | 0.2% | 1.10M | 1.10M |
| Common Stock Direct | 6/10/2026 | S · Sale | −614.00 | $86.89 | $53.35K | 0.1% | 1.10M | 1.10M |
| Total | −20K | -$1.67M | ||||||
Derivative Transactions0
No derivative transactions reported